Levocetirizine

# Levocetirizine ## Overview - **Classification**: Second-generation antihistamine, H1-receptor antagonist. - **Mechanism**: Potent, selective peripheral H1-receptor antagonist. Inhibits histamine release and reduces allergic inflammation. ## Primary Indications 1. **Perennial Allergic Rhinitis (PAR)** - Relief of sneezing, rhinorrhea, postnasal drip. 2. **Seasonal Allergic Rhinitis (SAR)** - Relief of sneezing, itchy eyes, runny nose. 3. **Chronic Idiopathic Urticaria (CIU)** - Relief of itching and reduction of hives. ## Adult Dosing ### Standard Dosing **Allergic Rhinitis (PAR, SAR) & Chronic Idioms Urticaria (CIU)** - **Dose**: **5 mg** - **Frequency**: Once daily - **Route**: Oral - **Duration**: As needed for symptoms. ### Dose Adjustments - **Renal Impairment**: - CrCl 50-79 mL/min: **5 mg** every other day - CrCl 10-49 mL/min: **5 mg** twice weekly - CrCl <10 mL/min: **Contraindicated** - **Hepatic Impairment**: No dose adjustment necessary. - **Elderly Patients**: - Start with **2.5 mg** daily if CrCl is 50-79 mL/min. - Adjust dose based on renal function, monitor closely. ## Pediatric Dosing ### Neonates (0-28 days) - **Dose**: Not recommended. - **Special Notes**: Safety and efficacy not established in this age group. ### Infants (1-12 months) - **Dose**: Not recommended. - **Special Notes**: Safety and efficacy not established in this age group. ### Children (6 months to <2 years) - **Indication**: Chronic Idiopathic Urticaria (CIU) only. - **Dose**: **1.25 mg** (2.5 mL oral solution) - **Frequency**: Once daily - **Maximum**: **1.25 mg/day** - **Special Notes**: Use oral solution; tablets are not appropriate. ### Children (2-5 years) - **Indication**: PAR, CIU. - **Dose**: **1.25 mg** (2.5 mL oral solution) - **Frequency**: Once daily - **Maximum**: **1.25 mg/day** - **Special Notes**: Oral solution recommended; assess swallowing ability for tablets. ### Children (6-11 years) - **Indication**: PAR, SAR, CIU. - **Dose**: **2.5 mg** - **Frequency**: Once daily - **Maximum**: **2.5 mg/day** - **Special Notes**: Available as 2.5 mg oral tablet or oral solution. ### Adolescents (12-18 years) - **Dose**: Follow adult dosing: **5 mg** - **Frequency**: Once daily - **Maximum**: **5 mg/day** - **Special Notes**: Tablets or oral solution are appropriate. ## Safety Information ### Contraindications - **Absolute**: Hypersensitivity to levocetirizine or cetirizine. - **Absolute**: End-stage renal disease (CrCl <10 mL/min). - **Absolute**: Hemodialysis patients. - **Absolute**: Children 6 months to 11 years with renal impairment. ### Common Adverse Effects - **Very Common (>10%)**: Somnolence (drowsiness), fatigue. - **Common (1-10%)**: Dry mouth, pharyngitis, headache, cough, nausea. - **Serious but Rare**: Angioedema, anaphylaxis, seizures, severe hepatotoxicity. ### Key Drug Interactions - **Central Nervous System Depressants (e.g., alcohol, sedatives)**: Potentiates CNS depression (drowsiness, impaired coordination). Avoid concurrent use. - **Ritonavir**: May increase levocetirizine levels. Monitor for increased adverse effects. - **Theophylline**: May slightly decrease levocetirizine clearance. Usually not clinically significant. ## Monitoring & Follow-up - **Before Treatment**: Assess renal function (CrCl) in elderly or those with suspected impairment. - **During Treatment**: Monitor for excessive sedation or drowsiness. - **Clinical Signs**: Watch for signs of hypersensitivity (rash, swelling, trouble breathing). ## Clinical Pearls - 💡 **Tip 1**: Take in the evening to minimize impact of potential drowsiness during the day. - 💡 **Tip 2**: Caution with activities requiring mental alertness (e.g., driving) until effects are known. - 💡 **Tip 3**: Can be taken with or without food. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.